High Risk of Metabolic Side Effects Among New Paediatric Antipsychotic Users in Sweden—A Register‐Based Study

Elin Eyfells Kimland, Anders Sundström, Sverre Wikström, Håkan Jarbin, Elin Dahlén

Open source

DOI
10.1002/pds.70482
Published
2026-09-22
Container
Pharmacoepidemiology and Drug Safety
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/pds.70482,
  title = {High Risk of Metabolic Side Effects Among New Paediatric Antipsychotic Users in Sweden—A Register‐Based Study},
  author = {Elin Eyfells Kimland and Anders Sundström and Sverre Wikström and Håkan Jarbin and Elin Dahlén},
  year = {2026},
  journal = {Pharmacoepidemiology and Drug Safety},
  doi = {10.1002/pds.70482},
  url = {https://doi.org/10.1002/pds.70482}
}

RIS

TY  - JOUR
TI  - High Risk of Metabolic Side Effects Among New Paediatric Antipsychotic Users in Sweden—A Register‐Based Study
AU  - Elin Eyfells Kimland
AU  - Anders Sundström
AU  - Sverre Wikström
AU  - Håkan Jarbin
AU  - Elin Dahlén
PY  - 2026
JO  - Pharmacoepidemiology and Drug Safety
DO  - 10.1002/pds.70482
UR  - https://doi.org/10.1002/pds.70482
ER  - 

APA

Kimland, E. E., Sundström, A., Wikström, S., Jarbin, H., & Dahlén, E. (2026). High Risk of Metabolic Side Effects Among New Paediatric Antipsychotic Users in Sweden—A Register‐Based Study. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.70482

Source records